Quantcast
Last updated on April 16, 2014 at 5:31 EDT

Latest insulin delivery Stories

2014-01-16 08:28:11

LONDON, Jan. 16, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: US Diabetes Management Devices Market Growth Trends, 2013 Short Description The Market Intelligence report provides critical market data for US diabetes management devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level....

2014-01-16 08:28:05

LONDON, Jan. 16, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: China Diabetes Management Devices Market, 2005 - 2018 Short Description The Market Intelligence report provides critical market data for China diabetes management devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level....

2013-10-08 23:23:03

Reportbuyer.com just published a new market research report: Global Insulin Delivery Devices Market Forecast to 2017. London (PRWEB) October 08, 2013 371 Million people had diabetes in 2012 and by 2030 this number is expected to rise to 552 Million. This finding by International Diabetes Federation (IDF) and similar results from studies done by organizations of repute like WHO, CDC, NHS etc. suggest that a huge patient population exists for the diabetes healthcare market. It is estimated...

2013-09-09 08:27:53

-- Funding Will Support Broad Scale Commercialization of CeQur PaQ® Insulin Delivery Device- HORW, Switzerland, Sept. 9, 2013 /PRNewswire/ -- CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the closing of a $27 million dollar Series B financing. The financing was led by two new private investors with the participation of all current shareholders, and will support manufacturing scale up for the CeQur PaQ(®) simple...

2013-06-22 12:21:30

- Data presented at the ADA 73rd Scientific Sessions suggest PaQ® may help patients requiring daily insulin injections maintain better glycemic control - HORW, Switzerland, June 22, 2013 /PRNewswire/ -- CeQur(®) SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that comprehensive data from a study of the company's PaQ(® )Insulin Delivery Device will be presented today and tomorrow at the American Diabetes Association...

2013-06-21 16:23:01

Development Continues With Data Presented at the American Diabetes Association (ADA) Scientific Sessions WEST CHESTER, Pa., June 21, 2013 /PRNewswire/ -- Animas Corporation announced today further promising results from the second phase of human clinical trials of a first-generation closed-loop insulin delivery system in development. Data investigating the predictive Hypoglycemia-Hyperglycemia Minimizer (HHM) System* demonstrated that the system is capable of maintaining safe glucose...

2013-06-04 12:27:44

--- Valeritas Expanding V-Go US Commercial Operations --- BRIDGEWATER, N.J., June 4, 2013 /PRNewswire/ -- Valeritas, makers of the V-Go(® )insulin delivery device, today announced that they have closed a structured debt financing with Capital Royalty L.P. which provides Valeritas with up to $100 million to further support the commercialization of the V-Go. "We are pleased to have Capital Royalty as a financial partner," said Kristine Peterson, Valeritas Chief Executive Officer....

2013-02-28 12:27:56

- Data presented at international diabetes conference suggest PaQ® device may offer safe, highly satisfying alternative to multiple daily insulin injections - HORW, Switzerland, Feb. 28, 2013 /PRNewswire/ -- CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that initial data from a study of the company's PaQ(® )Insulin Delivery Device were presented today at the 6(th) International Conference on Advanced...

2013-02-28 08:31:23

Predictive Glucose Control System in Development Shows Promising Ability to Minimize Number, Duration and Severity of Hypoglycemic Events with No Safety Concerns WEST CHESTER, Pa., Feb. 28, 2013 /PRNewswire/ -- Animas Corporation announced today positive results from the second phase of human clinical trials of a first-generation, closed-loop insulin delivery system in development, designed to predict a rise or fall in blood glucose and correspondingly increase, decrease, suspend...

2012-11-27 08:28:15

HORW, Switzerland, Nov. 27, 2012 /PRNewswire/ -- CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that the PaQ(® )Insulin Delivery Device has received CE Mark approval. PaQ has demonstrated the safety and efficacy required for marketing in Europe. PaQ is a discreet, wearable device that provides three days of consistent, basal insulin delivery as well as easy, on-demand bolus insulin for individuals with type 2 diabetes....